Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03490877 · ClinicalTrials.gov registry record
Scratch and Sleep Quantification in Atopic Dermatitis
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 45
- Enrollment target
NCT03490877: Completed study, sponsored by University of Rochester.
NCT03490877 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03490877 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Atopic dermatitis (AD) is a chronic type of eczema affecting approximately 10% of adults and 12% of children in the US. The intense itching (pruritus) associated with AD can be significantly disruptive to sleep and quality of life for both the patients and their caregivers. AD is challenging to describe and measure. The purpose of this study is to see if we can reliably measure how much people with AD scratch and how scratching interferes with sleep and quality of life by using digital sensors, sleep studies and patient-reported information.
Primary Outcome
To evaluate the agreement between the outcomes acquired by video annotation and accelerometry regarding scratch movement.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2018-07-13 |
| Est. Completion | 2019-09-30 |
What the finished NCT03490877 record still lists
NCT03490877 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03490877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03490877 about?
NCT03490877 is a clinical study titled "Scratch and Sleep Quantification in Atopic Dermatitis". Atopic dermatitis (AD) is a chronic type of eczema affecting approximately 10% of adults and 12% of children in the US. The intense itching (pruritus) associated with AD can be significantly disruptive to sleep and quality of life for both the patients and their caregivers. AD is challenging to desc...
What is the current status of trial NCT03490877?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2018-07-13. Estimated completion is 2019-09-30.
Who is sponsoring clinical trial NCT03490877?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI